Received Nov 3, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received one dose of the Shingrix and did not come back within the time frame to get the 2nd dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 70-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on 03-NOV-2022). The patient did not receive the 2nd dose of Shingrix.The patient experienced incomplete course of vaccination (Verbatim: received one dose of the Shingrix and did not come back within the time frame to get the 2nd dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 21-OCT-2025 The vaccine administration facility was the same as primary reporter.